Context Therapeutics Inc. (CNTX) vs Grace Therapeutics, Inc. (GRCE)
A side-by-side comparison of Context Therapeutics Inc. and Grace Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CNTX
Context Therapeutics Inc.
$0.34HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
GRCE
Grace Therapeutics, Inc.
$2.06HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — CNTX vs GRCE
growth of $100 · dividends reinvested · last 2yCNTX -81.9% (-57.5%/yr)GRCE -31.6% (-17.3%/yr)GRCE compounded faster over this window
CNTX GRCE
CNTX vs GRCE: by the numbers
- •GRCE is the larger company ($34M vs $31M market cap).
Metrics side by side
Valuation
| Metric | CNTX | GRCE |
|---|---|---|
| P/B ratio | 0.81 | 0.70 |
Profitability
| Metric | CNTX | GRCE |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -120.40% | -44.50% |
| ROIC | -126.84% | -52.61% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.